About Klinikum Ludwigshafen
Das Klinikum der Stadt Ludwigshafen ist ein Krankenhaus der Maximalversorgung in Ludwigshafen am Rhein. Klinikträger ist die Stadt Ludwigshafen. Die Rechtsform ist gemeinnützige GmbH. Das Klinikum ist nach der BASF und nach der Stadtverwaltung der drittgrößte Arbeitgeber in Ludwigshafen.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Abbott Medical Devices
7
Klinikum Ludwigshafen
6
Boehringer Ingelheim
4
German High-Grade Non-Hodgkin's Lymphoma Study Group
4
IHF GmbH - Institut für Herzinfarktforschung
4
Acacia Pharma Ltd
3
Prof. Dr. med. Dirk Schadendorf
3
Apellis Pharmaceuticals, Inc.
2
European Organisation for Research and Treatment of Cancer - EORTC
2
Medtronic Bakken Research Center
2
Pfizer
2
Clinical Trials at Klinikum Ludwigshafen
During the past decade, Klinikum Ludwigshafen conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 16 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 6 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Men With Germ Cell Cancer
1998-10-01
Unknown status
498
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
2001-05-01
Completed
608
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias
2000-08-01
2014-10-01
Completed
156
SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)
2002-05-01
2011-08-01
Completed
116
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Ludwigshafen" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Klinikum Ludwigshafen" with 6 trials
sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored and "IHF GmbH - Institut für Herzinfarktforschung"
with 4 trials sponsored. Other sponsors include 66 different institutions and
companies that sponsored additional 65 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Ludwigshafen"
#1 collaborator was "Bayer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Charite University, Berlin, Germany" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were
collaborators in the rest 49 trials.
Clinical Trials Conditions at Klinikum Ludwigshafen
According to Clinical.Site data, the most researched conditions in "Klinikum Ludwigshafen" are
"Atrial Fibrillation" (6 trials), "Coronary Artery Disease" (5 trials), "Lymphoma" (5 trials), "Heart Failure" (4 trials) and "Acute Coronary Syndrome" (3 trials). Many other conditions were trialed in "Klinikum Ludwigshafen" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Ludwigshafen
Most popular intervention types in "Klinikum Ludwigshafen" are "Drug" (63 trials), "Device" (16 trials), "Biological" (11 trials), "Procedure" (6 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (4 trials), "filgrastim" (4 trials) and "prednisone" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Ludwigshafen
The vast majority of trials in "Klinikum Ludwigshafen" are
93 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Klinikum Ludwigshafen
Currently, there are NaN active trials in "Klinikum Ludwigshafen".
undefined are not yet recruiting,
14 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 60 completed trials in Klinikum Ludwigshafen,
1 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Ludwigshafen, 5 "Phase 1"
clinical trials were conducted, 26 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 10 trials that are defined as “Not Applicable".
Departments of Klinikum Ludwigshafen
Klinikum Ludwigshafen has several departments that took part in Clinical trials: "Klinikum der Stadt Ludwigshafen; Medizinische Klinik A" - 5 trials, "Department of Anesthesiology and Intensive Care Medicine Klinikum Ludwigshafen" - 2 trials
Departments List
Name
City
Trials